The India Pharmaceutical Forum 2017 saw the chiefs of five top Indian firms - Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Lupin Ltd. and Zydus Cadila - share glimpses of quality “transformation” initiatives underway at their respective companies, and also of broader industry collaboration in the area despite some initial skepticism around such joint efforts.
Their reflections came against the backdrop of regulatory action against several Indian firms, including some of the frontline companies, over...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?